6
Oct
2026
LABOMED S.A.
Exhibitor at CPHI Milan 2026 stand 7G125, Integrated Pharma
About Us
Categories
-
Country/Region:Greece
-
On CPHI since:2018
-
Certificates:1
-
Employees:50 - 99
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 7G125, Integrated Pharma
Products Featured at CPHI Milan 2026
-
Product Carbocisteine oral solution 250mg/5ml & 750mg/5ml
Therapeutic category: Mucolytic agent
250mg/5ml is packed in BTx300ml and is registered as generic.
750mg/5ml is packed in BTx100ml, BTx200ml and is registered as hybrid. Added value: 1 spoon daily (vs 3 spoons with lowest strength) and sugar-free.
-
Product Methylphenidate hydrochloride oral solution 10mg/5ml
CNS stimulant (ADHD)
BT x150ml -
Product Sodium Oxybate oral solution 500mg/ml
CNS depressant (narcolepsy)
BT x180ml -
Product Oxycodone Hydrochloride oral solution 5mg/5ml, 50mg/5ml & 20mg/5ml
Opioid Analgesic
Oxycodone hydrochloride is a controlled substance.
5mg/5ml is packed in BTx250ml and is registered as generic.
50mg/5ml is packed in BTx120ml and is registered as generic.
20mg/5ml is packed in BTx150ml and is registered as hybrid. -
Product Oxybutynin oral solution 2.5mg/5ml & 5mg/5ml
Anticholinergic/antispasmodic
LABOSERVE Resources (1)
-
Brochure Laboserve Company Profile (short)
This is a short presentation of Laboserve added value services and generic products offered.
